Literature DB >> 14760277

Bilateral sensorineural deafness in adenosine deaminase-deficient severe combined immunodeficiency.

Wendy Albuquerque1, Hubert B Gaspar.   

Abstract

Adenosine deaminase deficiency presents with severe combined immunodeficiency and is treatable by bone marrow transplantation. With improved survival, the nonimmunologic manifestations of this condition are becoming apparent. We report a high incidence of bilateral sensorineural deafness in transplanted patients, which highlights the systemic nature of the disease.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14760277     DOI： 10.1016/j.jpeds.2003.10.055

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


  25 in total

1.  Adenosine deaminase deficient severe combined immunodeficiency presenting as atypical haemolytic uraemic syndrome.

Authors:  Olga Nikolajeva; Austen Worth; Rosie Hague; Nuria Martinez-Alier; Joanne Smart; Stuart Adams; E Graham Davies; H Bobby Gaspar
Journal:  J Clin Immunol       Date:  2015-04-15       Impact factor: 8.317

2.  Comparison of elapegademase and pegademase in ADA-deficient patients and mice.

Authors:  L Murguia-Favela; W Min; R Loves; M Leon-Ponte; E Grunebaum
Journal:  Clin Exp Immunol       Date:  2020-02-09       Impact factor: 4.330

3.  Myeloid dysplasia and bone marrow hypocellularity in adenosine deaminase-deficient severe combined immune deficiency.

Authors:  Robert Sokolic; Irina Maric; Chimene Kesserwan; Elizabeth Garabedian; I Celine Hanson; Margaret Dodds; Rebecca Buckley; Andrew C Issekutz; Naynesh Kamani; Kit Shaw; Ben Tan; Pawan Bali; Michael S Hershfield; Donald B Kohn; Alan S Wayne; Fabio Candotti
Journal:  Blood       Date:  2011-07-01       Impact factor: 22.113

Review 4.  Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Stem Cell Transplantation (HCT) for Severe Combined Immunodeficiency Patients: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT.

Authors:  Jennifer Heimall; Jennifer Puck; Rebecca Buckley; Thomas A Fleisher; Andrew R Gennery; Benedicte Neven; Mary Slatter; Elie Haddad; Luigi D Notarangelo; K Scott Baker; Andrew C Dietz; Christine Duncan; Michael A Pulsipher; Mort J Cowan
Journal:  Biol Blood Marrow Transplant       Date:  2017-01-06       Impact factor: 5.742

Review 5.  Long term outcomes of severe combined immunodeficiency: therapy implications.

Authors:  Jennifer Heimall; Morton J Cowan
Journal:  Expert Rev Clin Immunol       Date:  2017-09-23       Impact factor: 4.473

Review 6.  Recommendations for Screening and Management of Late Effects in Patients with Severe Combined Immunodeficiency after Allogenic Hematopoietic Cell Transplantation: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT.

Authors:  Jennifer Heimall; Rebecca H Buckley; Jennifer Puck; Thomas A Fleisher; Andrew R Gennery; Elie Haddad; Benedicte Neven; Mary Slatter; Skinner Roderick; K Scott Baker; Andrew C Dietz; Christine Duncan; Linda M Griffith; Luigi Notarangelo; Michael A Pulsipher; Morton J Cowan
Journal:  Biol Blood Marrow Transplant       Date:  2017-05-04       Impact factor: 5.742

7.  Non-infectious lung disease in patients with adenosine deaminase deficient severe combined immunodeficiency.

Authors:  C Booth; V E Algar; J Xu-Bayford; L Fairbanks; C Owens; H B Gaspar
Journal:  J Clin Immunol       Date:  2012-02-21       Impact factor: 8.317

Review 8.  How I treat ADA deficiency.

Authors:  H Bobby Gaspar; Alessandro Aiuti; Fulvio Porta; Fabio Candotti; Michael S Hershfield; Luigi D Notarangelo
Journal:  Blood       Date:  2009-07-28       Impact factor: 22.113

9.  ADA Deficiency: Evaluation of the Clinical and Laboratory Features and the Outcome.

Authors:  Deniz Cagdas; Pınar Gur Cetinkaya; Betül Karaatmaca; Saliha Esenboga; Cagman Tan; Togay Yılmaz; Ersin Gümüş; Safa Barış; Barış Kuşkonmaz; Tuba Turul Ozgur; Pawan Bali; Ines Santisteban; Diclehan Orhan; Aysel Yüce; Duygu Cetinkaya; Kaan Boztug; Michael Hershfield; Ozden Sanal; İlhan Tezcan
Journal:  J Clin Immunol       Date:  2018-05-09       Impact factor: 8.317

Review 10.  Consensus approach for the management of severe combined immune deficiency caused by adenosine deaminase deficiency.

Authors:  Donald B Kohn; Michael S Hershfield; Jennifer M Puck; Alessandro Aiuti; Annaliesse Blincoe; H Bobby Gaspar; Luigi D Notarangelo; Eyal Grunebaum
Journal:  J Allergy Clin Immunol       Date:  2018-09-05       Impact factor: 10.793
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.